Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Biocartis Idylla™ IDH1-2 Mutation Assay Kit

Products are for professional/laboratory use only

The Idylla IDH1-2 Mutation Assay Kit (RUO)1 can detect five mutations in the IDH1 gene and 10 mutations in the IDH2 gene, along with an integrated processing control. The turnaround time is approximately 95 minutes from sample to result. The assay performance has been evaluated at multiple sites in both the US and Europe.

  • Five mutations in IDH1 and 10 in IDH2 genes.
  • 95 minutes assay turnaround time.
  • Less than five minutes hands-on time.
  • Suitable for both FFPE or extracted DNA samples.
  • Highly sensitive and standardised.
  • Suitable for any lab.

SPECIMEN REQUIREMENTS

Extracted DNA

  • 50 μl extracted DNA
  • Concentration ≥ 10 ng/μl
  • DNA should be extracted from samples with ≥ 10% neoplastic cells

Also compatible with FFPE sections without DNA extraction

  • ≥ 10% neoplastic cells

 

Idylla IDH1-2 Mutation Assay Kit Brochure

Download Brochure >

Technical Sheet Idylla IDH1-2 Mutation Assay Kit

Download Technical Sheet >

References

¹ Idylla IDH1-2 Mutation Assay Kit is for Research Use Only (RUO), not for use in diagnostic procedures.



Request a Quote

Request Quote

Recent Posts

Devyser Genomic Blood Typing

A streamlined NGS solution for comprehensive blood typing, covering most relevant red blood cell, platelet, and neutrophil antigens in a single assay. Devyser Genomic Blood…

Read full article

Devyser Thalassemia v2

Thalassemia testing. Simplifed. Comprehensive NGS testing for thalassemia and sickle cell disease. Now with β-modifier detection, robust CNV analysis, and a streamlined workflow.Devyser Thalassemia v2…

Read full article

Bio-Techne – QuantideX® JAK2 V617F

Simplified, Sensitive, & Scalable JAK2 V617F Mutation DetectionThe QuantideX® qPCR JAK2 Kit delivers highly sensitive and quantitative detection of the JAK2 V617F mutation relative to…

Read full article